Skip to main content
. Author manuscript; available in PMC: 2012 Dec 19.
Published in final edited form as: J Nucl Med. 2012 Feb 17;53(4):538–545. doi: 10.2967/jnumed.111.096032

Figure 1.

Figure 1

Time activity-curve representing the mean of all patients, using iliac artery (red), prostate tumor (blue), benign prostatic hyperplasia (BPH) foci (purple) and normal prostate (green). Uptake is expressed in SUV (standardized uptake value). Tumor and BPH foci showed rapid uptake of 11C-Acetate in the prostate peaking ~3–5 minutes, followed by a relatively plateau after 10 minutes.